PI
HAE icon

PEAK6 Investments’s Haemonetics HAE Stock Holding History

PEAK6 Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,100
Closed -$91K – 4212
2023
Q1 		$91K Sell
1,100
-1,600
-59% -$130K ﹤0.01% 3550
2022
Q4 		$212K Buy
2,700
+1,100
+69% +$88.4K ﹤0.01% 3240
2022
Q3 		$118K Buy
+1,600
New +$115K ﹤0.01% 3992
2021
Q4 		– Sell
-3,100
Closed -$219K – 5377
2021
Q3 		$219K Sell
3,100
-25,600
-89% -$1.62M ﹤0.01% 3924
2021
Q2 		$1.91M Buy
+28,700
New +$2.03M ﹤0.01% 1948
2020
Q4 		– Sell
-11,900
Closed -$1.04M – 4799
2020
Q3 		$1.04M Buy
11,900
+10,600
+815% +$926K ﹤0.01% 2236
2020
Q2 		$116K Sell
1,300
-4,600
-78% -$465K ﹤0.01% 3728
2020
Q1 		$588K Buy
+5,900
New +$640K ﹤0.01% 1946
2019
Q4 		– Sell
-9,200
Closed -$1.16M – 3643
2019
Q3 		$1.16M Buy
9,200
+7,100
+338% +$901K 0.01% 1655
2019
Q2 		$253K Buy
+2,100
New +$207K ﹤0.01% 2715

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

PEAK6 Investments's HAE Position: Q3 2024 in Review

PEAK6 Investments sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 3,202 shares — an estimated $265K sold.

PEAK6 Investments first reported a position in HAE in Q3 2018 and held it in 16 quarters. The position peaked at $1.7M in Q3 2021. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • PEAK6 Investments reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,202 Haemonetics shares in Q3 2024, an estimated $265K.
  • PEAK6 Investments first reported a position in Haemonetics in Q3 2018 and held it in 16 quarters.
  • PEAK6 Investments's Haemonetics position peaked at $1.7M in Q3 2021.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.